Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5012d58bb33dc9709ccad873df226cd9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F11-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D255-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2004-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83711d09e00026311dafa7601ecc1cae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1d314ae9e9bc6a5d56f23fcd04354ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_679a42769bdb2536a635aecd0e75707d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de3d0f611f4a310977656137700f7500 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12d718bd9c8a8bc9d36761eb284fba97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9074665cc1255deb29ede6c04e40cafe |
publicationDate |
2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005038249-A1 |
titleOfInvention |
Anti-cancer 2,3-dihydro-1H-pyrrole[3,2-f] quinoline compolexes of cobalt and chromium |
abstract |
This invention relates to a class of heterocycles and their metal complexes, and is particularly concerned with the use of these compounds in the preparation of prodrugs or as prodrugs that may be activated under hypoxic conditions by enzymes or by therapeutic ionising radiation, in the treatment of cancer. The invention also relates to the use of these heterocycles and the corresponding metal complexes in the preparation of medicaments and to compositions including the heterocycles or their metal complexes and to methods for preparing these compounds. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10376164-B2 |
priorityDate |
2001-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |